Most disease-causing mutations that swap amino acids do so by making proteins less stable

As­cen­t­age Phar­ma, a Hong Kong-list­ed blood can­cer biotech, is plan­ning a dual list­ing in the US as it pre­pares for ad­di­tion­al drug launch­es, it …

Lilly has invested more than $20bn since 2020 to enhance and acquire manufacturing sites across the US and Europe. Credit: Katherine Welles/Shutterstock. Eli Lilly and